LISATA THERAPEUTICS, INC. Line of Credit Facility, Maximum Borrowing Capacity
LISATA THERAPEUTICS, INC. (LSTA) had Line of Credit Facility, Maximum Borrowing Capacity of $500.00 thousand as of 2006-05-19, per its 8-K filed 2012-08-15.
Discontinued › Notes › Debt › Line of Credit Facility
us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity · last filed 2012-08-15
- 2006-05-19: Line of Credit Facility, Maximum Borrowing Capacity $500.00K.
| Period end | Line of Credit Facility, Maximum Borrowing Capacity |
|---|---|
| 2006-05-19 | $500.00K 8-K · filed 2012-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |